Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1974 Apr;5(4):366–370. doi: 10.1128/aac.5.4.366

Human Pharmacology of 6-[d-α-(3-Guanylureido)-Phenylacetamido]- Penicillanic Acid (BL-P1654)

Gerald P Bodey 1, Noboru Horikoshi 1, Victorio Rodriguez 1
PMCID: PMC428976  PMID: 15825389

Abstract

BL-P1654 is a new α-substituted ureido penicillin which has broad-spectrum activity. Doses of 0.5 and 1.0 g administered by rapid intravenous injection produce mean peak serum concentrations of 40.7 and 80.8 μg/ml, respectively. The same doses administered by 1-h intravenous infusions produce mean peak serum concentrations of 22.6 and 47 μg/ml, respectively. The mean serum concentrations from 1 to 6 h after onset of administration of the drug are the same for both schedules. The mean serum concentration at 6 h after the rapid intravenous injection of 0.5- and 1.0-g doses of BL-P1654 are 3.4 and 5.4 μg/ml, respectively. A dose of 1.0 g every 4 h maintains a serum concentration of about 15 μg/ml. About 50 to 65% of the BL-P1654 is excreted in the urine during the first 6 h.

Full text

PDF
366

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acred P., Brown D. M., Knudsen E. T., Rolinson G. N., Sutherland R. New semi-synthetic penicillin active against Pseudomonas pyocyanea. Nature. 1967 Jul 1;215(5096):25–30. doi: 10.1038/215025a0. [DOI] [PubMed] [Google Scholar]
  2. Bodey G. P., Middleman E., Umsawadi T., Rodriguez V. Infections in cancer patients. Results with gentamicin sulfate therapy. Cancer. 1972 Jun;29(6):1697–1701. doi: 10.1002/1097-0142(197206)29:6<1697::aid-cncr2820290638>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  3. Bodey G. P., Stewart D. In vitro studies of semisynthetic alpha-(substituted-ureido) penicillins. Appl Microbiol. 1971 Apr;21(4):710–717. doi: 10.1128/am.21.4.710-717.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bodey G. P., Terrell L. M. In vitro activity of carbenicillin against gram-negative bacilli. J Bacteriol. 1968 May;95(5):1587–1590. doi: 10.1128/jb.95.5.1587-1590.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Price K. E., Leitner F., Misiek M., Chisholm D. R., Pursiano T. A. BL-P 1654, a new broad-spectrum penicillin with marked antipseudomonal activity. Antimicrob Agents Chemother (Bethesda) 1970;10:17–29. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES